Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
Without strong language on health equity, the document is of limited importance → Read More
A study of more than 2,000 projects funded from 2020 to 2022 shows scant evidence of a climate focus → Read More
Underrepresented groups are more present on company boards, but overall diversity is still limited → Read More
The new FAA's new safety requirement comes with a steep price tag → Read More
The US's largest protestant denomination says only men can lead congregations → Read More
Charles Schwab's survey on modern wealth found that younger generations are more likely to feel rich → Read More
The association warns caution in using the flawed metric, which among other things, does not consider race or ethnicity → Read More
Organizers of the 2024 Olympics are hoping to strike a sponsorship deal with the French luxury goods company → Read More
Modelo Especial overtook Bud Light to become the nation's most popular beer → Read More
The metric shows that New York City is enduring the worst air quality in the world → Read More
The CDC found that many food illness outbreaks are directly connected to workers showing up sick → Read More
Early-career scientists at the world's largest research employer are getting together to fight for better employment → Read More
America's prisons are full of mothers—that we feel bad for this one shows the power of white privilege → Read More
With weight loss medications, the line between healthcare and lifestyle can be blurry → Read More
Almost a third of Americans didn't seek care because of prices in 2022, 5% more than in 2020 → Read More
Florida governor Ron DeSantis's latest measures against DEI prompted a travel warning by the NAACP → Read More
AstraZeneca president Wang Lei said the company wants to be one that "loves the Communist Party" → Read More
The reported occurrence of gastrointestinal diseases on cruises is worse than pre-covid → Read More
Pfizer, Merck, J&J, Gilead, Eli Lilly, Amgen BMS, and AbbVie paid a combined $2 billion in taxes → Read More
Results from a phase three trial are encouraging for children with peanut allergies → Read More